Multiple Sclerosis Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
October 14, 2024 10:39 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Multiple Sclerosis - Pipeline...
Multiple Sclerosis Drugs Market Outlook 2024-2028, 2033 - A $48 Billion Global Opportunity Dominated by Biogen, Novartis, Roche, Bayer HealthCare, and Pfizer
May 16, 2024 08:00 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global multiple sclerosis drugs...
Global Multiple Sclerosis Treatment Market Report 2023: Sector is Projected to Reach $38.41 Million in 2031 at a CAGR of 4.3%
May 03, 2023 10:53 ET
|
Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global...
Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More
December 24, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
Worldwide Multiple Sclerosis Therapeutics Industry to 2027 - by Drug Class, Route of Administration, and Distribution Channel and Geography
April 14, 2021 05:08 ET
|
Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, and Distribution...